-
Merck and BGI forge genomic biomarker allianceMerck has teamed up with BGI, the world's largest genomics centre, to discover and develop of biomarkers and genomic technologies. Under the agreement, scientists from Merck and BGI will work toget2011/9/13
-
Sanofi CEO issues positive 2012 estimatesSanofi CEO Chris Viehbacher has told investors that the company expects growth in 2012 as it approaches the end of its 'patent cliff' and recent acquisitions begin to perform. Over the past three y2011/9/9
-
First-ever comprehensive study of species origins of nature-derived drugsIn a first-ever comprehensive study of the species origins of nature-derived drugs, it is shown that drug-producing species are concentrated and clustered in a limited number of families, refuting t2011/9/8
-
SFDA Deputy Commissioner Wu Zhen meets the Head of Iran's Innovation and Technology Cooperation CenterOn the morning of September 6, 2011, Wu Zhen, Deputy Commissioner of the State Food and Drug Administration (SFDA), met with the visiting Mr. Hamidreza Amirinia, Head of Innovation and Technology Coop2011/9/8
-
WHO and FIP sign landmark tuberculosis initiativeThe World Health Organization (WHO) and the International Pharmaceutical Federation (FIP) have signed a landmark initiative to improve engagement between pharmacists and tuberculosis health workers.2011/9/7
-
"National Safe Medication Month" campaign launched"National Safe Medication Month" campaign was launched in an all-round way on September 1, 2011. The theme of this years activity is "beware of online fraud selling counterfeit drugs". Centering on th2011/9/5
-
SFDA issues Operating Standards for Food Safety in Catering ServicesThe State Food and Drug Administration (SFDA) recently formally issued the Operating Standards for Food Safety in Catering Services to further raise the food safety awareness, integrity awareness and2011/9/2
-
FDA urged to revise generic drug risk rulesThe US Food and Drug Administration (FDA) has been urged to amend regulations preventing generic drug manufacturers from updating labelling, allowing them to warn patients about associated drug risks.2011/9/2
-
Study reveals how pharmaceutical managers can maximize the return on marketing investmentsModel depicts that detailing, relationships between sales representatives and medical doctors, is an extremely effective long-term marketing tool, while sampling has a stronger, short-term effect Res2011/9/1
-
FDA rejects Novartis gout medicationThe US Food and Drug Administration (FDA) has rejected canakinumab, a drug developed by Novatis to treat gout. The decision follows an 11-1 vote against approving the drug to treat gouty arthritis2011/8/31